Evaluation of the relation of BRAF inhibitor resistance and HIF1 regulation in malignant melanoma cell lines

被引：0
|
作者：
Baskin, Yasemin [1 ]
机构：
[1] Dokuz Eylul Univ, Inst Oncol, Alsancak, Turkey
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
5518
引用
收藏
页码：AB133 / AB133
页数：1
相关论文
共 50 条
  • [31] CpG island hypermethylation profile of human melanoma cell lines in relation to global methylation and mutations in BRAF and NRAS
    Tellez, Carmen S.
    Shen, Lanlan
    Oki, Yasuhiro
    Estecio, Marcos R. H.
    Gershenwald, Jeffrey E.
    Issa, Jean-Pierre J.
    CANCER RESEARCH, 2006, 66 (08)
  • [32] MECHANISMS OF RESISTANCE TO THE B-RAF INHIBITOR ZELBORAF IN FOUR MELANOMA CELL LINES
    Garg, E.
    Kong, X.
    Shi, H.
    Moriceau, G.
    Lo, R. S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 169 - 169
  • [33] Low inducible expression of p21Cip1 confers resistance to paclitaxel in BRAF mutant melanoma cells with acquired resistance to BRAF inhibitor
    Jang, Gun-Hee
    Kim, Na-Yeon
    Lee, Michael
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2015, 406 (1-2) : 53 - 62
  • [34] Low inducible expression of p21Cip1 confers resistance to paclitaxel in BRAF mutant melanoma cells with acquired resistance to BRAF inhibitor
    Gun-Hee Jang
    Na-Yeon Kim
    Michael Lee
    Molecular and Cellular Biochemistry, 2015, 406 : 53 - 62
  • [35] Synergistic activity of PARP inhibitor and ATR inhibitor in melanoma cell lines may depend on BRAF-V600 mutation status
    Giunta, E. F.
    Belli, V.
    Napolitano, S.
    De Falco, V.
    Vitiello, P. P.
    Terminiello, M.
    Caputo, V.
    Vitale, P.
    Zanaletti, N.
    Ciardiello, D.
    Argenziano, G.
    Martinelli, E.
    Martini, G.
    Troiani, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S248 - S249
  • [36] Role of WEE1 in cell cycle regulation of malignant melanoma
    Raatz, Y.
    Vera, J.
    Schoenherr, M.
    Bhattacharya, A.
    Simon, J. C.
    Kunz, M.
    EXPERIMENTAL DERMATOLOGY, 2011, 20 (02) : 199 - 199
  • [37] BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1
    Johannes Grimm
    Anita Hufnagel
    Marion Wobser
    Andreas Borst
    Sebastian Haferkamp
    Roland Houben
    Svenja Meierjohann
    Oncogenesis, 7
  • [38] BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1
    Grimm, Johannes
    Hufnagel, Anita
    Wobser, Marion
    Borst, Andreas
    Haferkamp, Sebastian
    Houben, Roland
    Meierjohann, Svenja
    ONCOGENESIS, 2018, 7
  • [39] RASA1 loss in a BRAF-mutated Langerhans cell sarcoma: a mechanism of resistance to BRAF inhibitor
    Jouenne, F.
    de Moura, C. Reger
    Lorillon, G.
    Meignin, V.
    Dumaz, N.
    Lebbe, C.
    Mourah, S.
    Tazi, A.
    ANNALS OF ONCOLOGY, 2019, 30 (07) : 1170 - 1172
  • [40] Synthesis of 4′-ester analogs of resveratrol and their evaluation in malignant melanoma and pancreatic cell lines
    Wong, Yong
    Osmond, Gregory
    Brewer, Kenneth I.
    Tyler, Douglas S.
    Andrus, Merritt B.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1198 - 1201
12345